This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
Leukemia Open Access 22 December 2022
-
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia
Leukemia Open Access 13 March 2021
-
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia
Scientific Reports Open Access 12 January 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Mullighan CG, Downing JR . Global genomic characterization of acute lymphoblastic leukemia. Semin Hematol 2009; 46: 3–15.
Pui CH, Carroll WL, Meshinchi S, Arceci RJ . Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol 2011; 29: 551–565.
Stanulla M, Schrappe M . Treatment of childhood acute lymphoblastic leukemia. Semin Hematol 2009; 46: 52–63.
Loughran SJ, Kruse EA, Hacking DF, de Graaf CA, Hyland CD, Willson TA et al. The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells. Nat Immunol 2008; 9: 810–819.
Mullighan CG, Miller CBS, Su X, Radtke I, Dalton J, Song G et al. ERG Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia. Blood (ASH Annual Meeting Abstracts) 2007; 110: 691.
Yeoh EJ, Ross ME, Shurtleff SA, Williams WK, Patel D, Mahfouz R et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002; 1: 133–143.
Harvey RC, Mullighan CG, Wang X, Dobbin KK, Davidson GS, Bedrick EJ et al. Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome. Blood 2010; 116: 4874–4884.
Zhang J, Mullighan CG, Harvey RC, Wu G, Chen X, Edmonson M et al. Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 2011; 118: 3080–3087.
Flohr T, Schrauder A, Cazzaniga G, Panzer-Grümayer R, van der Velden V, Fischer S et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 2008; 22: 771–782.
Kox C, Zimmermann M, Stanulla M, Leible S, Schrappe M, Ludwig WD et al. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia 2010; 24: 2005–2013.
Dörge P, Meissner B, Zimmermann M, Möricke A, Schrauder A, Bourquin JP et al. IKZF1 deletion is an independent predictor of outcome in pediatric acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol. Haematologica 2013; 98: 428–432.
Schrappe M, Reiter A, Zimmermann M, Harbott J, Ludwig WD, Henze G et al. Longterm results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000; 14: 2205–2222.
Clappier E, Auclerc MF, Rapion J, Bakkus M, Caye A, Khemiri A et al. ERG intragenic deletion (ERGdel) characterizes an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletion. Leukemia 2013; e-pub ahead of print 18 October 2013; doi:10.1038/leu.2013.277.
Tsuzuki S, Taguchi O, Seto M . Promotion and maintenance of leukemia by ERG. Blood 2011; 117: 3858–3868.
Uckun FM, Gaynon PS, Sensel MG, Steinherz PG, Trigg ME, Heerema NA et al. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study. J Clin Oncol 1997; 15: 2214–2221.
Acknowledgements
We thank all participants and personnel involved in ALL-BFM 2000 and Ester Mejstrikova for sharing her expertise in flow cytometric assessment of CD2-positivity. This work was supported by EU FP7 (ENCCA), the Madeleine Schickedanz-Kinderkrebsstiftung, Deutsche Krebshilfe, GACR-P302/12/G101, UNCE204012, MZCR-00064203.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
MZ, GC and MST designed the study; MZ, OZ, BM and PD performed laboratory work; MZ, JS and MZI performed data analysis; CE performed analyses on relapse samples; AM and MS contributed to data interpretation and co-ordinate the ALL-BFM study group (chair: MS); RK and CRB performed MRD analyses; ATS performed cytogenetic and molecular genetic investigations; LK and PR performed immunophenotyping; MZ, JZ and MST wrote the manuscript; all authors criticially evaluated the manuscript and approved its content.
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Zaliova, M., Zimmermannova, O., Dörge, P. et al. ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia. Leukemia 28, 182–185 (2014). https://doi.org/10.1038/leu.2013.282
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2013.282
This article is cited by
-
Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial
Leukemia (2023)
-
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia
Leukemia (2021)
-
High STAP1 expression in DUX4-rearranged cases is not suitable as therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia
Scientific Reports (2018)
-
Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis
Annals of Hematology (2017)
-
Identification of ETV6-RUNX1-like and DUX4-rearranged subtypes in paediatric B-cell precursor acute lymphoblastic leukaemia
Nature Communications (2016)